top of page

A Study of Rilvegostomig Plus Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection

Clinicaltrials.gov ID

NCT06109779

Status

Recruiting

Study Type

Interventional, Phase 3

Sponsor

AstraZeneca

Start Date

December 8, 2023

Anticipated End Date

June 30, 2029

Study Contact

Name: AstraZeneca Clinical Study Information Center

Phone Number: 1-877-240-9479

Email: information.center@astrazeneca.com


About the Study

A global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator's choice of chemotherapy in participants with BTC after surgical resection with curative intent.

Conditions

  • Biliary Tract Cancer

Inclusion/Exclusion Criteria?

Primary, Secondary, Other Outcome Measures??

Locations in Canada

  • BC Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada

  • Nova Scotia Health Authority/QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 2Y9, Canada

  • Kingston Health Sciences Centre, Kingston, Ontario, K7L 5P9, Canada

  • The Ottawa Hospital, Ottawa, Ontario, K1H 8L6, Canada

  • Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada

  • Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada

  • McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada

Apply Now

About the Study

A global study to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator's choice of chemotherapy in participants with BTC after surgical resection with curative intent.

Conditions

  • Biliary Tract Cancer

Interventions

DRUG:

  • Rilvegostomig

  • Capecitabine

  • Gemcitabine/Cisplatin

  • S-1 [Tegafur/Oteracil/gimeracil]

Locations in Canada

  • BC Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada

  • Nova Scotia Health Authority/QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 2Y9, Canada

  • Kingston Health Sciences Centre, Kingston, Ontario, K7L 5P9, Canada

  • The Ottawa Hospital, Ottawa, Ontario, K1H 8L6, Canada

  • Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada

  • Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada

  • McGill University Health Centre, Montreal, Quebec, H4A 3J1, Canada

bottom of page